Telephone: +46 (0) 8 555 293 20
Born in 1950. M.B.A., founder and principal shareholder of BioGaia, where he was President 1996-2016. Since March 2016 Group President.
In the capacity of Group President, Peter Rothschild has the overall responsibility for the BioGaia Group’s research and development activities and is a working Chairman of the group companies TwoPac (BioGaia’s production company) and CapAble (BioGaia’s venture in innovative delivery systems) as well as of the associated company MetaboGen. Also Chairman of the Board of Infant Bacterial Therapeutics (IBT) and with board assignments in Looft Industries AB.
Holds 370,334 class A shares and 379,666 class B shares via Annwall & Rothschild Investment AB.